HZO vs OXM

The company presents a stark contrast between deep value metrics and deteriorating fundamental growth. While the Piotroski F-Score of 5/9 indicates a stable financial baseline, the business is struggling with a -16.50% YoY revenue decline and a -71.4% crash in YoY EPS growth. Valuation is highly attractive on a Price-to-Book (0.71) and Price-to-Sales (0.29) basis, but the negative ROE and poor Quick Ratio (0.30) suggest significant liquidity risks and operational inefficiency. The 'Strong Buy' analyst consensus conflicts with a bearish technical trend (10/100), suggesting a speculative value play rather than a growth investment.

OXM exhibits severe fundamental weakness, highlighted by a critical Piotroski F-Score of 2/9, indicating deteriorating financial health. While the stock appears cheap on a Price-to-Sales basis (0.43) and offers a high dividend yield, these are offset by negative profit margins and a dangerously low Quick Ratio of 0.31. The long-term price trend is heavily bearish, and the current price of $42.84 trades at a premium to the analyst target price of $37.50. Overall, the combination of shrinking revenue and poor liquidity suggests a high-risk profile.